Glad we are on the same page! The only thing I don't quite understand is whether they can share the data with Merck execs under NDA before running it through their advisory board, PIs, and a TLD PR for the shareholders? Or would they get in trouble, if that's somehow investigated to be true?
In our case, we didn't have things resting on Phase 3 trial data as much as NWBO does....although, we all believe it's going to be a home run!
News 
Market Data 
Discover 
AI
